Desh Rakshak Aushdhalaya
35.20
-1.80(-4.86%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-4.86%
1M-6.31%
6M-7.59%
1Y+122.93%
5Y+720.51%
View Company Insightsright
More news about Desh Rakshak Aushdhalaya
09Sept 25
Desh Rakshak Aushdhalaya Approves Allotment of 12.6 Lakh Equity Shares at Rs. 22 Per Share
Desh Rakshak Aushdhalaya Limited, an Ayurvedic and herbal products manufacturer, has approved a preferential issue of 12,60,000 equity shares to non-promoter category allottees at Rs. 22 per share, raising Rs. 2.77 crore. The allotment is divided among four investors: Mr. Navneet Chaturvedi and Ms. Ruchika Chaturvedi (5,50,000 shares each), and Ms. Victoria Rao Pippal and Ms. Rashmi Kumari (80,000 shares each). This move will increase the company's share capital from Rs. 4.44 crore to Rs. 5.70 crore, with the total number of equity shares rising from 44,38,324 to 56,98,324.
27Aug 25
Desh Rakshak Aushdhalaya Secures BSE Nod for Rs 27.72 Crore Preferential Share Issue
Desh Rakshak Aushdhalaya Limited, an Ayurvedic and herbal product manufacturer, has received in-principle approval from BSE for a preferential share issue. The company plans to issue 12,60,000 equity shares at Rs. 22.00 per share to non-promoters, aiming to raise Rs. 27.72 crore. The approval is granted under SEBI regulations, with specific compliance requirements including adherence to the Companies Act 2013 and submission of a listing application within 20 days of allotment. This capital raise could potentially fuel growth initiatives for the Haridwar-based firm.
25Aug 25
Desh Rakshak Aushdhalaya's Internal Auditor Steps Down Citing Professional Commitments
Mrs. Bhumika Parwani, Internal Auditor of Desh Rakshak Aushdhalaya Limited, has resigned effective August 25, 2025, citing other professional commitments. She will hand over all necessary documents to ensure a smooth transition. The company, which manufactures Ayurvedic and herbal products, has not yet announced a replacement.
13Aug 25
Desh Rakshak Aushdhalaya Reports Q1 Growth and Appoints New Directors
Desh Rakshak Aushdhalaya Limited, an Ayurvedic and herbal products manufacturer, reported a 20.1% year-over-year increase in revenue from operations for Q1 FY2026, reaching ₹129.99 lakh. Net profit grew by 2.8% to ₹9.59 lakh, with Basic EPS improving to ₹0.22. The company appointed two Additional Independent Directors: Mrs. Cheena Golani and Mr. Rajesh Kumar Gupta, each for a five-year term starting August 13, 2025, subject to shareholder approval. Statutory auditors issued an unmodified opinion on the quarterly results.
Desh Rakshak Aushdhalaya
35.20
-1.80
(-4.86%)
1 Year Returns:+122.93%
Industry Peers
Windlas Biotech
790.15
(+0.55%)
Jeena Sikho Lifecare
699.20
(+0.52%)
Blue Jet Healthcare
554.80
(-2.56%)
Abbott
28,850.00
(-0.14%)
Sunrest Lifescience
42.05
(-2.21%)
Zenith Drugs
54.60
(+2.25%)
Pfizer
5,001.00
(+0.57%)
FDC
414.10
(+0.24%)